Literature DB >> 7642397

[Cellular immune defect caused by postoperative irradiation in patients with squamous epithelial carcinomas of the upper aerodigestive tract].

H Maier1, V Daniel, F Heimlich, C Frank, G Opelz.   

Abstract

The effect of locoregional postoperative radiation therapy on cellular immunity was investigated in 11 patients with head and neck cancer. During the course of the radiation therapy, total lymphocyte counts, CD8+ lymphocyte counts and especially CD4+ lymphocyte counts decreased significantly. The mean CD4+ lymphocyte counts dropped from 739/microliters to 183/microliters (p < 0.001) and the average CD4+/CD8+ ratio also decreased significantly. In addition all patients showed impaired in vitro lymphocyte stimulation responses to several mitogens, with reductions found to be 10% to 50% of normal responses. Within 3-4 weeks after radiation therapy there was a slight increase of CD4+ lymphocyte counts and the in vitro lymphocyte stimulation responses showed a tendency to normalization. These results indicate that locoregional postoperative radiation therapy in patients with head and neck cancer can induce a severe impairment of cellular immunity.

Entities:  

Mesh:

Year:  1995        PMID: 7642397

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  3 in total

1.  Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.

Authors:  Kai Johannes Lorenz; Heinz Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-17       Impact factor: 2.503

2.  [Long-term changes in peripheral blood leukocyte and lymphocyte populations in ENT-carcinoma patients. A flow cytometric study in 346 ENT-carcinoma patients and 31 healthy controls].

Authors:  J Ostwald; S Dommerich; U Schulz; B Kramp
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

3.  [Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].

Authors:  K J Lorenz; H Maier
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.